ARWA LLC’s Merck MRK Stock Holding History

ARWA LLC’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.49M	Sell	11,712 -385	-3%	-$45.1K	0.62%	42
2026 Q1	$1.48M	Sell	12,097 -2,193	-15%	-$253K	0.74%	38
2025 Q4	$1.5M	Buy	+14,290	New	+$1.34M	0.88%	25

Other funds holding MRK

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

ARWA LLC's MRK Position: Q2 2026 in Review

ARWA LLC reduced its Merck (MRK) stake by 3.2% in Q2 2026, selling an estimated $45.1K and leaving 11,712 shares worth $1.49M. The position accounts for 0.62% of the portfolio, ranked #42.

ARWA LLC first reported a position in MRK in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.5M in Q4 2025. 3,814 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

ARWA LLC held 11,712 shares of Merck worth $1.49M as of Q2 2026.
ARWA LLC sold 385 Merck shares in Q2 2026, an estimated $45.1K.
Merck made up 0.62% of ARWA LLC's portfolio in Q2 2026, its #42 holding.
ARWA LLC first reported a position in Merck in Q4 2025 and has held it in 3 quarters since.
ARWA LLC's Merck position peaked at $1.5M in Q4 2025.
3,814 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on ARWA LLC's 13F filing for Q2 2026, filed 24 Jul 2026.